109 related articles for article (PubMed ID: 30555973)
1. Idiopathic macular telangiectasia type 2: A six-year study with multimodal imaging of a presumed unilateral case.
Zarei M; Mazloumi M; Karkhaneh R; Roohipoor R
J Curr Ophthalmol; 2018 Dec; 30(4):368-373. PubMed ID: 30555973
[TBL] [Abstract][Full Text] [Related]
2. Multimodal Imaging of Macular Telangiectasia Type 2: Focus on Vascular Changes Using Optical Coherence Tomography Angiography.
Toto L; Di Antonio L; Mastropasqua R; Mattei PA; Carpineto P; Borrelli E; Rispoli M; Lumbroso B; Mastropasqua L
Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT268-76. PubMed ID: 27409482
[TBL] [Abstract][Full Text] [Related]
3. Macular Telangiectasia Type 2: A Classification System Using MultiModal Imaging MacTel Project Report Number 10.
Chew EY; Peto T; Clemons TE; Sallo FB; Pauleikhoff D; Leung I; Jaffe GJ; Heeren TFC; Egan CA; Charbel Issa P; Balaskas K; Holz FG; Gaudric A; Bird AC; Friedlander M
Ophthalmol Sci; 2023 Jun; 3(2):100261. PubMed ID: 36846105
[TBL] [Abstract][Full Text] [Related]
4. Optical Coherence Tomography Angiography Findings in Type-2 Macular Telangiectasia.
Nalcı H; Şermet F; Demirel S; Özmert E
Turk J Ophthalmol; 2017 Oct; 47(5):279-284. PubMed ID: 29109897
[TBL] [Abstract][Full Text] [Related]
5. Macular Dystrophy with Bilateral Macular Telangiectasia Related to the CYP2U1 Pathogenic Variant Assessed with Multimodal Imaging Including OCT-Angiography.
El Matri K; Falfoul Y; Habibi I; Chebil A; Schorderet D; El Matri L
Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828401
[TBL] [Abstract][Full Text] [Related]
6. MULTIMODAL IMAGING OF UNILATERAL IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2: A FIVE-YEAR STUDY.
Manayath GJ; Verghese S; Narendran V
Retin Cases Brief Rep; 2024 Mar; 18(2):230-235. PubMed ID: 36026689
[TBL] [Abstract][Full Text] [Related]
7. Epiretinal Neovascularization: A Novel OCT Angiography Finding in Macular Telangiectasia Type 2.
Ayachit AG; Reddy LU; Joshi S; Ayachit GS
Ophthalmol Retina; 2019 Jun; 3(6):516-522. PubMed ID: 31174674
[TBL] [Abstract][Full Text] [Related]
8. Fundus Autofluorescence Imaging in Macular Telangiectasia Type 2: MacTel Study Report Number 9.
Pauleikhoff L; Heeren TFC; Gliem M; Lim E; Pauleikhoff D; Holz FG; Clemons T; Balaskas K; ; Egan CA; Charbel Issa P
Am J Ophthalmol; 2021 Aug; 228():27-34. PubMed ID: 33775659
[TBL] [Abstract][Full Text] [Related]
9. High-resolution photoreceptor imaging in idiopathic macular telangiectasia type 2 using adaptive optics scanning laser ophthalmoscopy.
Ooto S; Hangai M; Takayama K; Arakawa N; Tsujikawa A; Koizumi H; Oshima S; Yoshimura N
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5541-50. PubMed ID: 21642620
[TBL] [Abstract][Full Text] [Related]
10. Multimodal Imaging Findings and Treatment with Dexamethasone Implant in Three Cases of Idiopathic Macular Telangiectasia Type 1.
Cirafici P; Musolino M; Saccheggiani M; Traverso CE; Nicolò M
Case Rep Ophthalmol; 2021; 12(1):92-97. PubMed ID: 33976663
[TBL] [Abstract][Full Text] [Related]
11. Radial Hemorrhage in Henle Layer in Macular Telangiectasia Type 2.
Au A; Hou K; Baumal CR; Sarraf D
JAMA Ophthalmol; 2018 Oct; 136(10):1182-1185. PubMed ID: 30054619
[TBL] [Abstract][Full Text] [Related]
12. Staging of macular telangiectasia: power-Doppler optical coherence tomography and macular pigment optical density.
Chin EK; Kim DY; Hunter AA; Pilli S; Wilson M; Zawadzki RJ; Werner JS; Park SS
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4459-70. PubMed ID: 23716628
[TBL] [Abstract][Full Text] [Related]
13. OCT Angiography Findings of Tamoxifen Retinopathy: Similarity with Macular Telangiectasia Type 2.
Lee S; Kim HA; Yoon YH
Ophthalmol Retina; 2019 Aug; 3(8):681-689. PubMed ID: 31068263
[TBL] [Abstract][Full Text] [Related]
14. Familial asymptomatic macular telangiectasia type 2.
Gillies MC; Zhu M; Chew E; Barthelmes D; Hughes E; Ali H; Holz FG; Scholl HP; Charbel Issa P
Ophthalmology; 2009 Dec; 116(12):2422-9. PubMed ID: 19815294
[TBL] [Abstract][Full Text] [Related]
15. Demographic and Multimodal Imaging Features of Macular Telangiectasia Type 2: Korean Macular Telangiectasia Type 2 Study - Report No. 2.
Kim YH; Chung YR; Oh J; Kim SW; Lee CS; Yun C; Lee B; Ahn SM; Choi EY; Jang S; Lee K
Ophthalmic Epidemiol; 2021 Oct; 28(5):436-443. PubMed ID: 33459094
[No Abstract] [Full Text] [Related]
16. Multicolor imaging in macular telangiectasia-a comparison with fundus autofluorescence.
Govindahari V; Fraser-Bell S; Ayachit AG; Invernizzi A; Nair U; Nair DV; Lupidi M; Singh SR; Rajendran A; Zur D; Gallego-Pinazo R; Marco RD; Cagini C; Cozzi M; Chhablani J
Graefes Arch Clin Exp Ophthalmol; 2020 Nov; 258(11):2379-2387. PubMed ID: 32803329
[TBL] [Abstract][Full Text] [Related]
17. Multimodal imaging of macular telangiectasia type 2 in a pediatric patient.
Moussa M; Leila M; Moussa O
Am J Ophthalmol Case Rep; 2021 Jun; 22():101082. PubMed ID: 33948521
[TBL] [Abstract][Full Text] [Related]
18. Eight-year multimodal follow-up of recurrent idiopathic acute exudative polymorphous vitelliform maculopathy.
Astakhov YS; Astakhov SY; Lisochkina AB; Nechiporenko PA
J Fr Ophtalmol; 2020 Jun; 43(6):500-516. PubMed ID: 32147214
[TBL] [Abstract][Full Text] [Related]
19. CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHY.
Matet A; Yzer S; Chew EY; Daruich A; Behar-Cohen F; Spaide RF
Retina; 2018 Jan; 38 Suppl 1(Suppl 1):S67-S78. PubMed ID: 29016451
[TBL] [Abstract][Full Text] [Related]
20. Timing of ocular examination and retinal imaging for the diagnosis of type 2 macular telangiectasia (MacTel).
Sharief S; Venkatesh R; Mangla R; Chhablani J
Eur J Ophthalmol; 2023 Nov; 33(6):NP79-NP81. PubMed ID: 36788478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
